Cetuximab in combination with oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) in the first-line treatment of patients with epidermal growth factor receptor (EGFR)-expressing metastatic colorectal cancer: An international phase II study. - Díaz,R.ubio E.; Tabernero,J.; van Cutsem,E. (Proc ASCO, 2005)